USFDA approves Pfizer’s Litfulo for adults and adolescents with severe alopecia areata
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
This product will be manufactured at Lupin's Pithampur facility in India
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Subscribe To Our Newsletter & Stay Updated